Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Jundishapur Journal of Natural Pharmaceutical Products is Scopus-indexed (Q3, CiteScore 2.2), WoS ESCI. Published by Brieflands.
Checked against the index lists dated .
ISSN 1735-7780Verify ISSN ↗2228-7876Verify ISSN ↗
Publisher: Brieflands
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 42 / 79 | 47th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q3, CiteScore 2.2.
Jundishapur Journal of Natural Pharmaceutical Products is Q3 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 42 of 79), by CiteScore 2025.
Jundishapur Journal of Natural Pharmaceutical Products is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.2, which places it in quartile Q3 at the 47th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.278, quartile Q3, with an H-index of 35.
Jundishapur Journal of Natural Pharmaceutical Products is published by Brieflands. Its print ISSN is 1735-7780 and its online ISSN is 2228-7876.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Jundishapur Journal of Natural Pharmaceutical Products has an h-index of 36 and a 2-year mean of 1.4 citations per paper (OpenAlex). Its Scopus CiteScore is 2.2, quartile Q3. On 2-year citations it ranks #37 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Jundishapur Journal of Natural Pharmaceutical Products published 83 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from Iran (87.8%), Iraq (3.1%) and China (2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.